VASO
VASO Corp
Key Financials
Gross Profit
$54.7M
↑ 5.0%
Operating Income
$-2891000
↓ 1114.4%
Net Income
$1.6M
↑ 65.0%
Revenue
$89.1M
↑ 2.7%
EPS (Diluted)
$0.01
0.0%
Shareholders' Equity
$29.4M
↑ 6.2%
Cash & Equivalents
$35.0M
↑ 33.4%
Total Assets
$88.3M
↑ 6.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 4/16/2026 | View on SEC |
| SCHEDULE 13D | 4/10/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 2/12/2026 | View on SEC |
| 8-K | 12/19/2025 | View on SEC |
| DEFA14A | 11/26/2025 | View on SEC |
| 8-K | 11/20/2025 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| DEF 14A | 11/5/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VASO |
| Company Name | VASO Corp |
| CIK | 839087 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 516-997-4600 |